· Original article
Uniqlo India revenue rises 44% as store expansion continues
Uniqlo India posted Rs 1,724 crore in FY26 revenue and Rs 253 crore in profit, with plans to add stores and strengthen its digital channels.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Read the original source and publication date in each article.
Results: 1,928 · Page 36 / 161
· Original article
Uniqlo India posted Rs 1,724 crore in FY26 revenue and Rs 253 crore in profit, with plans to add stores and strengthen its digital channels.
· Original article
CGGR holdings changes for October 19, 2026, show an $18.3 million Amazon addition, broader buying and reductions in three semiconductor stocks.
· Original article
Wendt earnings doubled to ₹6 crore in Q2 FY27 as revenue rose 28%, with higher volumes and manufacturing cost savings supporting profit growth.
· Original article
Mitsui Fudosan earnings show a record ¥2,445 distribution for March–August 2026, with 97.2% occupancy and rent increases on new and renewed leases.
· Original article
Intuitive Surgical earnings fell on a $450 million antitrust charge in Q3 2026, despite 22% revenue growth and higher robotic-surgery procedures.
· Original article
Intuitive Surgical shares fell after Q3 revenue rose 22%, while a settlement charge hit earnings and full-year procedure guidance stayed measured.
· Original article
Supermicro revenue estimates exceed prior guidance for fiscal Q1 2027 as AI demand strengthens. Preliminary gross margins also beat the earlier range.
· Original article
ACT Energy began trading on OTCQX on October 23, 2026, retaining its ACXAF symbol after upgrading from OTCQB. Its Toronto ticker remains ACX.
· Original article
IDBI Bank sale plans would leave the government and LIC as public shareholders without board seats, while Fairfax awaits RBI clearance for the deal.
· Original article
eMudhra shares fell nearly 20% on October 22 as a certificate security incident drew government scrutiny, despite limited direct revenue exposure.
· Original article
Celcuity trial results presented on October 24 detail progression-free survival, tumor responses and treatment discontinuations in advanced breast cancer.
· Original article
MSIG UK appointments put Tim Harris in the interim underwriting role, pending regulatory approval, with Stephanie Belcourt joining as Claims Director.
Charts and market data by TradingView. Availability and delays vary by exchange.